Manufacturing Biotherapeutics to GMP standard for clinical trials can be one of the most difficult hurdles to overcome. Below are a number of facilities capable of manufacturing clinical and pre-clinical grade therapeutics including plasmid, oligonucleotides and viral vectors. There are also a selection of facilities capable of conducting the range of tests necessary to meet safety standards.
CRISPR, ready, go!!
A step towards treatment of congenital deafness with gene therapy
Treating allergy with a single vaccine?
Involving patients in research, we can and should
Copyright ©2016 European Society for Gene and Cell Therapy | Website by OFEC